Healthcare -
Biotechnology - NASDAQ - US
$ 2.45
6.52 %
$ 170 M
Market Cap
-0.79
P/E
IKT - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities IKT - Inhibikase Therapeutics, Inc.
8.41 M
LAST VALUE
-54.77%
2 YEAR CAGR
84.08%
5 YEAR CAGR
0.00%
10 YEAR CAGR